Home Infusion Therapy
Home infusion therapy providers delivering IV medications, nutritional support, and specialty drugs in home and clinic settings.
- 4
- Verticals
Overview
Home Infusion Therapy covers providers delivering IV medications, nutritional support, and specialty drugs in home and clinic settings. It is a growing, specialty-pharmacy-adjacent category led by scaled players (Option Care Health, CVS Coram) that combines pharmacy, nursing, and logistics.
Demand is driven by the shift of infusion from hospital to lower-cost home and ambulatory settings and by growth in specialty and biologic drugs. It is a consolidating, capability-intensive business at the intersection of home care and specialty pharmacy.
Market snapshot
No discrete Census NAICS code under home health. Home infusion spans home health (621610) and pharmacy classifications, so the segment is not separately sized here.
Business model & economics
Revenue model
Drug margin plus nursing and infusion-service fees
Key economics
- Recurring revenue
- Moderate–High
- EBITDA margin
- Drug-margin- and mix-dependent
- Capex intensity
- Moderate
recurring chronic infusion
Characteristics
- Shift of infusion from hospital to home and ambulatory.
- Specialty and biologic drug growth.
- Combines pharmacy, nursing, and logistics.
M&A deal context
Who’s acquiring
- Home-infusion & specialty-pharmacy platforms
- Pharmacy strategics
- PE-backed consolidators
What’s driving deals
- Site-of-care shift to home infusion.
- Specialty-drug growth.
- Consolidation of capability-intensive providers.
Verticals in this segment
Find Home Infusion Therapy acquisition targets
Search Acquisera’s index for companies classified under Home Infusion Therapy (4.6.2) and build a targeted deal pipeline.
Search companies